Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis

Clinical trial NCT01739660 · COMPLETED

Trial details

NCT number: NCT01739660
Sponsor: Savient Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Kidney Disease Stage 5

Start date: 2012-12-01
Primary completion: 2013-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.